Garry Neil
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
Avalo Therapeutics, Inc. (AVTX)
Proxy statement
Current -
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Avalo Therapeutics, Inc. (AVTX) | Chief Executive Officer, President, Chairman of the Board and principal executive officer | $475,000 | $1,075,362 |
| 2022 | Avalo Therapeutics, Inc. (AVTX) | Chief Executive Officer, President, Chairman of the Board and principal executive officer | $468,900 | $1,332,828 |
| 2021 | Avalo Therapeutics, Inc. (AVTX) | Chief Executive Officer, President, Chairman of the Board and principal executive officer | $423,000 | $1,234,071 |
| 2020 | Avalo Therapeutics, Inc. (AVTX) | Chief Scientific Officer | $372,932 | $2,688,804 |
| 2019 | Avalo Therapeutics, Inc. (AVTX) | Chief Scientific Officer | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.